INS and metabolic dysfunction-associated steatotic liver disease: They act as insulin sensitizers and reduce insulin resistance which is the main metabolic abnormality in NAFLD.17 The mechanism by which vildagliptin reduces body weight include its increasing insulin sensitivity in over weight NAFLD patients like metformin.